
|Videos|January 27, 2021
Visus CEO updates on lead product candidate, 2021 pipeline
Author(s)OT Staff Reports
Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR and Broadwood conflict over proposed Alcon merger continues
2
FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy
3
Ocular surface: Targeted therapies for a multifactorial problem
4
Increasing the knowledge base of GA is key to individualizing patient therapy
5